Holistic health is a major trend. It is estimated that the market for cosmetotextiles – the integration of cosmetics into textiles, generally on the basis of microcapsules – will be worth 500 million euro in 2013. Peclers, the Paris trend agency, is presenting this inspiring new form of “wellbeing”.
The Swiss style expert, Jeroen van Rooijen, is prophesizing the dawn of a new era, away from tradition and retro and geared towards individual functionality, practical wellbeing and passionate authenticity. All these signs and predictions point towards major change and new beginnings. New beginnings that Schoeller has no intention of missing.Holistic health is a major trend. It is estimated that the market for cosmetotextiles – the integration of cosmetics into textiles, generally on the basis of microcapsules – will be worth 500 million #
iLoad – the reloadable drug delivery textile:
Textiles and their functions are constantly evolving. Intelligent, highly-developed technologies such as energear, the energy retrieval system from Schoeller that can equip textiles with various applications with capabilities never seen before. The integration of cosmetics or medication (under medical supervision) into textiles offers revolutionary possibilities, such as skincare via clothing.
The increased wellbeing in combination with additional functionality makes cosmetotextiles “active” promoters of our everyday comfort. Schoeller's first groundbreaking response to this trend bears the name iLoad and has already been distinguished with the coveted Swiss Technology Award 2011.
iLoad is a textile carrier material that can be individually loaded and regenerated with beneficial or therapeutic substances. “The cornerstone has been laid for this project; now the task is to examine and further develop possible application technologies,” explains Hans-Jürgen Hübner, CEO of Schoeller Medical AG. To this end, Schoeller is taking a highly scientific approach of a kind unusual among textile companies and has purchased a laboratory with high quality research and analysis equipment, facilities for chemical synthesis and preliminary microbiological clarification.
As a general practice, Schoeller does not just stick to proven textile structures, but breaks new ground and invests in the future of medicine, such as with an initial product line for the area of incontinence. With partnership-based developments, the company is seeking individual solutions and designs tailored solutions geared closely to customer requirements.
This may take the form of new distribution channels such as online shops or customer care at point of sale, where, for example, effective substances for recharging iLoad textiles can be bought. In any event, Schoeller firmly intends to be among the frontrunners in the major health trend and offers interested potential business partners intelligent possibilities for exciting cooperation.
Schoeller